About Paul Armentano: Paul Armentano is the Deputy Director of NORML and faculty member at Oaksterdam Unviversty. His writing and research has appeared in over 750 publications, scholarly and/or peer reviewed journals, as well as more than a dozen textbooks and anthologies. He is a regular contributor to TheHill.com, AlterNet.org, and Freedom Leaf. Mr. Armentano is the co-auothr of "Marijuana is Safer: So Why Are We Driving People to Drink?" which has been licensed and translated internationally. His latest book is called "The Citizen's Guide to State-By-State Marijuana Laws". He is the 2013 Freedom Law School Health Freedom Champion of the Year and the 2013 Alfred R. Lindesmith award recipient in the achievement in the field of scholarship.
Mr. Armentano was the principal investigator for defense counsel in US vs Schweder, the first federal evidentiary since 1973 hearing to challenge the constitutionality of cannabis as a schedule one controlled substance. He was also an expert in a successful Canadian constitutional challenge (Crown versus Allard) preserving qualified patients' rights to grow cannabis at home. Mr. armentano previously provided online content to the TheAnswerPage.com, an online medical educational resource that provides daily education to healthcare professionals in 120 countries, as well as Continuing Medical Education credit. A version of this curriculum is now required in New York state for any physician who wishes to participate in the state's medical cannabis program.
About NORML: The National Organization for the Reform of Marijuana Laws. Since its founding in 1970, NORML has provided a voice in the public policy debate for those Americans who oppose marijuana prohibition and favor an end to the practice of arresting marijuana smokers. A nonprofit public-interest advocacy group, NORML represents the interests of the tens of millions of Americans who smoke marijuana responsibly. NORML's mission is to move public opinion sufficiently to legalize the responsible use of marijuana by adults, and to serve as an advocate for consumers to assure they have access to high quality marijuana that is safe, convenient and affordable. (Fyi : NORML has a great newsletter that I have been subscribed to for almost ten years. Check it out.)
-Marijuana in the main stream (over half of the US polling YES for legalization)
-What we're learning from legal states - - - "We have not seen [in the 30 states] that have enacted marijuana laws, starting with California in 1996...not a single one of those states has ever gone back and recriminalized marijuana."
-Lack of uptick in use with young teens or access in jurisdictions where marijuana is regulated.
-Paul Armentano Video Lecture : "Facts vs. Fears : Countering Common Misconceptions about Medicinal Cannabis" - - - "The most frustrating aspect of marijuana policy in America [at the federal level] is we do not have an evidence based policy...[it is] 180 degrees removed from what relevant science is telling us."
-Using PubMed to research Marijuana - - - "Outside of tabbaco, marijuana is the most studied plant on Earth...[there is] nearly 26,000 individual, peer reviewed studies of marijuana...That is more than twice the volume of literature dedicated to Ibeprofin...It's more than 20 times the available literature to hydrocodone."
-"We have a long history of human use than we have conventional substances we consume everyday...The problem isn't we don't know enough about cannabis, [it's that] we have public policies that are divorced from what the available science tells us."
-The Ole Miss Federal Marijuana Farm (link to LA Times article) and how it is used for clinical research across the country
-The Compassionate Investigational New Drug Program of 1978 and the patients who receive 300 rolled marijuana cigarettes a month from the US Government & what studies on these patients tell us.
-Why was marijuana originally made illegal?
-Creating change where prohibition still exists
Hosted by Stefan Lawson. 8/8/17
Please subscribe, share, leave reviews, or comments. We would love to hear your feedback.
Subscribe on iTunes here
Subscribe on Youtube here